CONMED CORPORATION Interest Expense
CONMED CORPORATION (CNMD) reported Interest Expense of $7.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-07-29
- CONMED CORPORATION interest expense for the quarter ending 2026-06-30 was $7.88M, a 0.75% increase year-over-year.
- CONMED CORPORATION interest expense for the quarter ending 2025-12-31 was $7.37M, a 16.78% decline year-over-year.
- CONMED CORPORATION interest expense for the quarter ending 2025-09-30 was $7.61M, a 17.79% decline year-over-year.
- CONMED CORPORATION interest expense for the quarter ending 2025-06-30 was $7.82M, a 18.44% decline year-over-year.
- CONMED CORPORATION interest expense for fiscal 2025 was $31.09M, a 16.65% decline from fiscal 2024.
- CONMED CORPORATION interest expense for fiscal 2024 was $37.30M, a 6.23% decline from fiscal 2023.
- CONMED CORPORATION interest expense for fiscal 2023 was $39.77M, a 37.61% increase from fiscal 2022.
- CONMED CORPORATION interest expense for fiscal 2022 was $28.91M, a 18.54% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.88M 10-Q · filed 2026-07-29 | $14.94M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $14.98M derived: sum of 2 quarters · filed 2026-02-17 | $22.80M derived: sum of 3 quarters · filed 2026-07-29 | $31.09M 10-K · filed 2026-02-17 |
| 2025-09-30 | $7.61M 10-Q · filed 2025-11-06 | $15.43M derived: sum of 2 quarters · filed 2026-07-29 | $23.72M 10-Q · filed 2025-11-06 | $32.57M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $7.82M 10-Q · filed 2026-07-29 | $16.11M 10-Q · filed 2026-07-29 | $24.97M derived: sum of 3 quarters · filed 2026-07-29 | $34.22M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $8.29M 10-Q · filed 2025-05-01 | $17.14M derived: sum of 2 quarters · filed 2026-02-17 | $26.39M derived: sum of 3 quarters · filed 2026-02-17 | $35.99M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $18.11M derived: sum of 2 quarters · filed 2026-02-17 | $27.70M derived: sum of 3 quarters · filed 2026-02-17 | $37.30M 10-K · filed 2026-02-17 |
| 2024-09-30 | $9.25M 10-Q · filed 2025-11-06 | $18.84M derived: sum of 2 quarters · filed 2025-11-06 | $28.44M 10-Q · filed 2025-11-06 | $37.94M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $9.59M 10-Q · filed 2025-07-31 | $19.19M 10-Q · filed 2025-07-31 | $28.69M derived: sum of 3 quarters · filed 2026-02-17 | $38.71M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $9.59M 10-Q · filed 2025-05-01 | $19.10M derived: sum of 2 quarters · filed 2026-02-17 | $29.12M derived: sum of 3 quarters · filed 2026-02-17 | $39.11M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $19.52M derived: sum of 2 quarters · filed 2026-02-17 | $29.52M derived: sum of 3 quarters · filed 2026-02-17 | $39.77M 10-K · filed 2026-02-17 |
| 2023-09-30 | $10.02M 10-Q · filed 2024-10-31 | $20.02M derived: sum of 2 quarters · filed 2024-10-31 | $30.27M 10-Q · filed 2024-10-31 | $39.71M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $10.00M 10-Q · filed 2024-08-01 | $20.25M 10-Q · filed 2024-08-01 | $29.70M derived: sum of 3 quarters · filed 2025-02-18 | $38.23M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $10.26M 10-Q · filed 2024-04-25 | $19.70M derived: sum of 2 quarters · filed 2025-02-18 | $28.23M derived: sum of 3 quarters · filed 2025-02-18 | $34.16M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $17.98M derived: sum of 2 quarters · filed 2025-02-18 | $23.91M derived: sum of 3 quarters · filed 2025-02-18 | $28.91M 10-K · filed 2025-02-18 |
| 2022-09-30 | $8.54M 10-Q · filed 2023-10-26 | $14.46M derived: sum of 2 quarters · filed 2023-10-26 | $19.46M 10-Q · filed 2023-10-26 | $27.03M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $5.93M 10-Q · filed 2023-07-27 | $10.93M 10-Q · filed 2023-07-27 | $18.49M derived: sum of 3 quarters · filed 2024-02-28 | $26.64M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.00M 10-Q · filed 2023-04-27 | $12.57M derived: sum of 2 quarters · filed 2024-02-28 | $20.71M derived: sum of 3 quarters · filed 2024-02-28 | $30.13M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $15.71M derived: sum of 2 quarters · filed 2024-02-28 | $25.13M derived: sum of 3 quarters · filed 2024-02-28 | $35.48M 10-K · filed 2024-02-28 |
| 2021-09-30 | $8.14M 10-Q · filed 2022-10-27 | $17.57M derived: sum of 2 quarters · filed 2022-10-27 | $27.92M 10-Q · filed 2022-10-27 | $39.03M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $9.42M 10-Q · filed 2022-07-28 | $19.77M 10-Q · filed 2022-07-28 | $30.89M derived: sum of 3 quarters · filed 2023-02-21 | $42.83M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $10.35M 10-Q · filed 2022-05-05 | $21.46M derived: sum of 2 quarters · filed 2023-02-21 | $33.41M derived: sum of 3 quarters · filed 2023-02-21 | $44.81M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $23.06M derived: sum of 2 quarters · filed 2023-02-21 | $34.46M derived: sum of 3 quarters · filed 2023-02-21 | $44.05M 10-K · filed 2023-02-21 |
| 2020-09-30 | $11.94M 10-Q · filed 2021-10-28 | $23.34M derived: sum of 2 quarters · filed 2021-10-28 | $32.94M 10-Q · filed 2021-10-28 | $43.26M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $11.40M 10-Q · filed 2021-07-29 | $20.99M 10-Q · filed 2021-07-29 | $31.31M derived: sum of 3 quarters · filed 2022-02-22 | $42.49M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $9.59M 10-Q · filed 2021-04-29 | $19.91M derived: sum of 2 quarters · filed 2022-02-22 | $31.09M derived: sum of 3 quarters · filed 2022-02-22 | $42.92M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $10.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $21.49M derived: sum of 2 quarters · filed 2022-02-22 | $33.33M derived: sum of 3 quarters · filed 2022-02-22 | $42.70M 10-K · filed 2022-02-22 |
| 2019-09-30 | $11.17M 10-Q · filed 2020-10-29 | $23.01M derived: sum of 2 quarters · filed 2020-10-29 | $32.38M 10-Q · filed 2020-10-29 | $37.91M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $11.84M 10-Q · filed 2020-07-30 | $21.21M 10-Q · filed 2020-07-30 | $26.74M derived: sum of 3 quarters · filed 2021-02-22 | $31.95M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $9.37M 10-Q · filed 2020-04-30 | $14.90M derived: sum of 2 quarters · filed 2021-02-22 | $20.11M derived: sum of 3 quarters · filed 2021-02-22 | $25.20M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $10.74M derived: sum of 2 quarters · filed 2021-02-22 | $15.83M derived: sum of 3 quarters · filed 2021-02-22 | $20.65M 10-K · filed 2021-02-22 |
| 2018-09-30 | $5.21M 10-Q · filed 2019-10-31 | $10.30M derived: sum of 2 quarters · filed 2019-10-31 | $15.12M 10-Q · filed 2019-10-31 | $20.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $5.09M 10-Q · filed 2019-08-01 | $9.91M 10-Q · filed 2019-08-01 | $14.79M derived: sum of 3 quarters · filed 2020-02-24 | $19.59M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $4.82M 10-Q · filed 2019-04-26 | $9.70M derived: sum of 2 quarters · filed 2020-02-24 | $14.50M derived: sum of 3 quarters · filed 2020-02-24 | $18.90M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $9.69M derived: sum of 2 quarters · filed 2020-02-24 | $14.08M derived: sum of 3 quarters · filed 2020-02-24 | $18.20M 10-K · filed 2020-02-24 |
| 2017-09-30 | $4.81M 10-Q · filed 2018-11-02 | $9.20M derived: sum of 2 quarters · filed 2018-11-02 | $13.32M 10-Q · filed 2018-11-02 | $17.23M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $4.40M 10-Q · filed 2018-08-02 | $8.52M 10-Q · filed 2018-08-02 | $12.43M derived: sum of 3 quarters · filed 2019-02-25 | $16.29M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $4.12M 10-Q · filed 2018-04-26 | $8.03M derived: sum of 2 quarters · filed 2019-02-25 | $11.89M derived: sum of 3 quarters · filed 2019-02-25 | $15.65M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $7.77M derived: sum of 2 quarters · filed 2019-02-25 | $11.53M derived: sum of 3 quarters · filed 2019-02-25 | $15.36M 10-K · filed 2019-02-25 |
| 2016-09-30 | $3.86M 10-Q · filed 2017-11-02 | $7.62M derived: sum of 2 quarters · filed 2017-11-02 | $11.45M 10-Q · filed 2017-11-02 | $13.03M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $3.76M 10-Q · filed 2017-07-27 | $7.59M 10-Q · filed 2017-07-27 | $9.16M derived: sum of 3 quarters · filed 2018-02-26 | $10.67M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $3.83M 10-Q · filed 2017-04-27 | $5.41M derived: sum of 2 quarters · filed 2018-02-26 | $6.91M derived: sum of 3 quarters · filed 2018-02-26 | $8.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $3.08M derived: sum of 2 quarters · filed 2018-02-26 | $4.57M derived: sum of 3 quarters · filed 2018-02-26 | $6.03M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.50M 10-Q · filed 2016-10-28 | $2.99M derived: sum of 2 quarters · filed 2016-10-28 | $4.45M 10-Q · filed 2016-10-28 | $5.99M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $1.49M 10-Q · filed 2016-07-28 | $2.95M 10-Q · filed 2016-07-28 | $4.49M derived: sum of 3 quarters · filed 2017-02-27 | $6.03M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $1.46M 10-Q · filed 2016-05-02 | $3.00M derived: sum of 2 quarters · filed 2017-02-27 | $4.54M derived: sum of 3 quarters · filed 2017-02-27 | $6.11M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $3.08M derived: sum of 2 quarters · filed 2017-02-27 | $4.65M derived: sum of 3 quarters · filed 2017-02-27 | $6.11M 10-K · filed 2017-02-27 |
| 2014-09-30 | $1.54M 10-Q · filed 2015-10-23 | $3.11M derived: sum of 2 quarters · filed 2015-10-23 | $4.57M 10-Q · filed 2015-10-23 | $6.05M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $1.57M 10-Q · filed 2015-07-27 | $3.03M 10-Q · filed 2015-07-27 | $4.51M derived: sum of 3 quarters · filed 2016-02-23 | $5.90M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $1.46M 10-Q · filed 2015-04-24 | $2.94M derived: sum of 2 quarters · filed 2016-02-23 | $4.33M derived: sum of 3 quarters · filed 2016-02-23 | $5.71M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $2.86M derived: sum of 2 quarters · filed 2016-02-23 | $4.25M derived: sum of 3 quarters · filed 2016-02-23 | $5.61M 10-K · filed 2016-02-23 |
| 2013-09-30 | $1.38M 10-Q · filed 2014-10-24 | $2.77M derived: sum of 2 quarters · filed 2014-10-24 | $4.13M 10-Q · filed 2014-10-24 | $5.53M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $1.38M 10-Q · filed 2014-07-25 | $2.75M 10-Q · filed 2014-07-25 | $4.15M derived: sum of 3 quarters · filed 2015-02-23 | $5.49M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $1.37M 10-Q · filed 2014-04-25 | $2.76M derived: sum of 2 quarters · filed 2015-02-23 | $4.11M derived: sum of 3 quarters · filed 2015-02-23 | $5.66M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $2.74M derived: sum of 2 quarters · filed 2015-02-23 | $4.29M derived: sum of 3 quarters · filed 2015-02-23 | $5.73M 10-K · filed 2015-02-23 |
| 2012-09-30 | $1.34M 10-Q · filed 2013-10-28 | $2.90M derived: sum of 2 quarters · filed 2013-10-28 | $4.33M 10-Q · filed 2013-10-28 | $5.83M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $1.55M 10-Q · filed 2013-07-29 | $2.99M 10-Q · filed 2013-07-29 | $4.48M derived: sum of 3 quarters · filed 2014-02-24 | $6.15M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $1.44M 10-Q · filed 2013-04-29 | $2.93M derived: sum of 2 quarters · filed 2014-02-24 | $4.60M derived: sum of 3 quarters · filed 2014-02-24 | $6.31M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $3.16M derived: sum of 2 quarters · filed 2014-02-24 | $4.87M derived: sum of 3 quarters · filed 2014-02-24 | $6.68M 10-K · filed 2014-02-24 |
| 2011-09-30 | $1.67M 10-Q · filed 2012-10-29 | $3.38M derived: sum of 2 quarters · filed 2012-10-29 | $5.18M 10-Q · filed 2012-10-29 | $7.03M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $1.71M 10-Q · filed 2012-07-30 | $3.51M 10-Q · filed 2012-07-30 | $5.36M derived: sum of 3 quarters · filed 2013-02-25 | $7.11M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $1.80M 10-Q · filed 2012-05-01 | $3.65M derived: sum of 2 quarters · filed 2013-02-25 | $5.40M derived: sum of 3 quarters · filed 2013-02-25 | $7.17M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $3.59M derived: sum of 2 quarters · filed 2013-02-25 | $5.36M derived: sum of 3 quarters · filed 2013-02-25 | $7.11M 10-K · filed 2013-02-25 |
| 2010-09-30 | $1.75M 10-Q · filed 2011-11-01 | $3.52M derived: sum of 2 quarters · filed 2011-11-01 | $5.27M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $1.77M 10-Q · filed 2011-08-09 | $3.52M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $7.09M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |